Structural deficiencies in the design or construction process are the probable cause of a recent scare at the Pfizer project, according to The Real Deal. Complex renovations on older buildings — particularly those involving floor additions, cantilevered sections, or redistribution of loads through an existing frame — require rigorous structural analysis at every stage. Real estate attorney and structural engineering expert Barry LePatner noted that such projects demand meticulous review to verify that existing structures can safely absorb new weight and altered load paths. When any step in that process is handled inadequately, the downstream consequences can be significant. LePatner characterized careful, thorough structural analysis as the essential safeguard between a successful outcome and a serious failure.
ParkPoint Perspective
This incident is a signal that execution risk in adaptive reuse and vertical expansion projects is frequently underestimated at the underwriting stage. When developers modify existing frames — rather than building to a clean structural specification — the margin for analytical error compresses sharply. This suggests that investors in value-add or repositioning strategies should scrutinize not only design credentials but the depth of third-party peer review embedded in the pre-construction process, particularly on aging urban assets where original structural documentation may be incomplete.
Source: The Real Deal